Skip to content
Hair Pipeline
← Recruiting trials
NCT07901426Active, not recruiting

Evaluation of the Scalp Skin Care Effects of Premium Revitalizing Elixir and Topical 5% Minoxidil

Evaluation of the Scalp Skin Care Effects of Premium Revitalizing Elixir and Minoxidil 5% Topical Solution

In the register

The register attaches this trial to Minoxidil (topical), currently at “Approved” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.

What the registry records

Status
Active, not recruiting
Declared phase
Not applicable (NA in the registry)
Sponsor
Hungkuang University
Participants (registry)
40
Start
June 2026
Primary completion
December 2026 (planned)
Study completion
January 2027 (planned)
Last registry update
November 2026
Countries
Taiwan

Conditions studied: Scalp Health, Alopecia, Hair Condition, Hair Loss, Sebum Production, Hair Health, Hair Thinning, Balding

Interventions: Base formula only, Base formula plus Centella asiatica extracellular vesicles, IGF-1 & FGF-7, Base formula plus Centella asiatica and ginger extracellular vesicles, IGF-1 & FGF-7, 5% Topical Minoxidil Solution

Full record on ClinicalTrials.gov ↗

Other trials of Minoxidil (topical)

  • NCT07529977Phase 3Not yet recruiting

    Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

  • NCT07273799Phase 3Not yet recruiting

    Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia

  • NCT06924632Phase 3Completed

    Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

  • NCT07056933Not yet recruiting

    Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia

  • NCT07012486Early phase 1Recruiting

    Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia

  • NCT07080931Phase 3Completed

    Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia

  • NCT07076706Phase 2Completed

    Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

  • NCT05888922Phase 3Active, not recruiting

    Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

  • NCT06043349Phase 4Status unknown

    Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia

  • NCT04721548Phase 3Completed

    Treatment of Androgenetic Alopecia in Men for 24 Weeks

  • NCT05296863Phase 3Completed

    Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia

  • NCT02486848Withdrawn

    Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil

Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.